PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists find 'brake-override' proteins that enable development of some cancers

Scientists find 'brake-override' proteins that enable development of some cancers
2011-07-10
(Press-News.org) Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.

The study, which recently appeared in the early online edition of the Proceedings of the National Academy of Sciences, illuminates the roles of two nearly identical proteins, Cks1 and Cks2. These proteins were known to be overexpressed in many cancers, but scientists hadn't understood why. Now it appears that Cks proteins' overexpression enables cancerous growth by nullifying a natural defense against uncontrolled cell division.

"An initial cancer-promoting gene mutation can push a cell to grow faster, but the cell often detects that something is wrong and sends a signal to its DNA replication machinery to slow down," said Steven I. Reed, a professor in the Scripps Research Department of Molecular Biology and senior author of the study. "We found that when the Cks proteins are overexpressed, they cause incipient cancer cells to ignore that braking signal."

Speeding Past the Checkpoint

Reed's lab focuses on the basic biology of cell division, and Cks proteins are known to be involved in normal cell division from embryogenesis onwards. Recently, in a routine investigation of the function of Cks proteins in cells, Reed's team used a chemical known as thymidine to temporarily halt the cell division process, to artificially synchronize the growth of two different groups of cells—one with normal Cks expression, and the other with Cks overexpression. To the researchers' surprise, the Cks-overexpressing cells failed to stop dividing.

"That was a serendipitous observation," said Reed. "It led us to hypothesize that these Cks proteins, when overexpressed, are preventing cells from responding to a normal growth-braking signal."

As a dividing cell unravels its chromosomes, replicates them, and becomes two new cells, it encounters safety "checkpoints," at which the cell division process should stop if the correct signals are not in place. Thymidine inhibits cell division by producing a stop signal at what is known as the "intra-S-phase checkpoint." But somehow, Cks overexpression causes cells to speed past that checkpoint.

Reed and his team observed that the checkpoint-override effect turned out to require a Cks expression level three to four times higher than normal—the same Cks overexpression level they observed in cell lines derived from human breast tumors. "That's probably not a coincidence," said Reed.

Reed's team created a simple model of Cks's function in cancer, inserting a mutant, cell-division-promoting "oncogene" into human breast-derived cells. The oncogene's protein product, known as cyclin E, pushed the cell towards uncontrolled division, which—as expected—triggered an intra-S-phase checkpoint response, so that the rate of cell division went sharply down. "When we overexpressed Cks, the cell division rate went back up again," said Reed.

Sampling real breast cancer cells from a tumor bank, Reed's team found that cells with high levels of cyclin E also tended to have high levels of Cks. Since neither protein directly influences the level of the other, the implication was that an initial oncogenic overactivation of cyclin E must in most cases be followed by Cks overexpression to keep a cell on the path to full-blown cancerous growth. "The statistical link between the cyclin-E and Cks levels was so strong that it could not have been a coincidence," said Reed.

Cks's cancer-enabling potential appears to be a broad one. When Reed's team looked at incipient cancer cells whose growth was driven by a different oncogene, h-Ras, they again found that the oncogene provoked checkpoint-dependent slower growth, whereas Cks overexpression partially nullified it and allowed cell division to proceed almost as normal.

Looking Ahead

In recent years, other researchers have noted that an initial oncogene activation can trigger a slightly different kind of growth arrest in cells. The phenomenon, known as oncogene-induced cellular senescence, is believed to underlie the slow or stopped growth of skin moles and some benign cancers. "It has been shown that this induced senescent state depends in part on the persistent activation of cell-cycle checkpoints, so presumably it is related to the process affected by Cks," said Reed.

Reed and his team are now trying to determine the precise molecular events through which Cks proteins exert their checkpoint-nullifying effect in cancer. At the same time, they are looking for ways to use their new knowledge against Cks-overexpressing cancers. The most direct strategy would be to treat cancer, or prevent it in people with inherited predispositions, simply by using a drug to reduce the activity of Cks proteins.

"We know that we can delete half of the Cks genes from mice without any deleterious effects, and this reduces the frequency of tumor formation," said Reed. "So the chances are we could find a way to reduce Cks proteins' activity enough to prevent their checkpoint-override effect while still allowing their essential cell functions."



INFORMATION:

The first authors of the paper, "Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins," are Vasco Liberal and Hanna-Stina Martinsson-Ahlzéna, both alumni of the Reed lab at Scripps Research. The other co-authors are Jennifer Liberal, an alumna of the Scripps Research laboratory of Clare H. McGowan; Charles H. Spruck, assistant professor, Sanford Burnham Research Institute (also a Reed Lab alumnus); Martin Widschwendter, professor of women's cancer at University College, London; and Clare H. McGowan, formerly associate professor in the Department of Molecular Biology at Scripps Research. For more information, see http://www.pnas.org/content/early/2011/06/22/1102434108.abstract .

The study was supported by the National Cancer Institute and by the U.K. Department of Health.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see www.scripps.edu .

[Attachments] See images for this press release:
Scientists find 'brake-override' proteins that enable development of some cancers

ELSE PRESS RELEASES FROM THIS DATE:

Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial

2011-07-10
Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). "Amrubicin showed significant improvements in tumor shrinkage, symptom control and progression-free survival over topotecan without improving overall survival, the primary endpoint of the trial," said principal ...

TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to date

2011-07-10
In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer (NSCLC), TEMLA showed a significantly higher diagnostic yield, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). Diagnostic yield refers to the likelihood that a procedure will provide the necessary information to establish a diagnosis. In the study, 617 patients ...

Endosonography followed by surgical staging improves quality of life, according to ASTER study

2011-07-10
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). "Given that assessment of lymph glands using the endoscopic approach was more effective, better tolerated by patients and no more expensive than the surgical approaches, we recommend that investigation ...

Cancer patients with blood clots gain no benefit from adding IVCF to fondaparinux

2011-07-10
Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. "This is the first prospective study to evaluate the treatment of venous thromboembolism (VTE) or blood clots in cancer patients and is ...

Concussion baseline important for accurate future assessment in at-risk youth athletes

2011-07-10
SAN DIEGO, CA – Creating a baseline for each youth athlete is a critical part of accurate future concussion assessment, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Differences in how females and males scored on a standardized concussion assessment tool were also investigated. "Our research analyzed whether the new Sport Concussion Assessment Tool-2 (SCAT2) has any variability in data for youth athletes and whether gender makes a difference on the scores," said presenting researcher, ...

New research points to a possible gender link in knee injuries

2011-07-10
SAN DIEGO, CA – Gender may be associated with an increased risk of cartilage lesions in anterior cruciate ligament (ACL) injured knees, according to research being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. "Having articular cartilage lesions (a hole or rough spot in the cartilage of the knee) is considered a predictor of future osteoarthritis-a debilitating joint condition," said lead author Jan Harald Roetterud, MD, from Akershus University Hospital, Lørenskog, Norway. "Our research is exciting because it highlights ...

Graft size and patient age may be predictor of need for future ACL revisions

2011-07-10
SAN DIEGO, CA – A smaller sized hamstring graft in an anterior cruciate ligament (ACL) reconstruction patient less than 20 years old may increase revision rates, according to research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego today. "Hamstring grafts are commonly used in ACL reconstruction surgeries and vary in size, with the average being 8mm in diameter. Our research illustrated that when a patient was younger than 20 years old and had a graft of less than 8mm, they were more likely to have a future revision surgery," ...

Previous cancer history increases chances of clotting disorders after knee surgery, study suggests

2011-07-10
SAN DIEGO, CA – A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure. "A history of malignancy has not been widely recognized as a significant risk factor for developing a VTE (venous thromboembolytic event) following knee arthroscopy," ...

Ancestry of polar bears traced to Ireland

Ancestry of polar bears traced to Ireland
2011-07-10
An international team of scientists has discovered that the female ancestor of all living polar bears was a brown bear that lived in the vicinity of present-day Britain and Ireland just prior to the peak of the last ice age -- 20,000 to 50,000 years ago. Beth Shapiro, the Shaffer Associate Professor of Biology at Penn State University and one of the team's leaders, explained that climate changes affecting the North Atlantic ice sheet probably gave rise to periodic overlaps in bear habitats. These overlaps then led to hybridization, or interbreeding -- an event that caused ...

A gene implicated in speech regulates connectivity of the developing brain

2011-07-10
Foxp2, a gene involved in speech and language, helps regulate the wiring of neurons in the brain, according to a study which will be published on July 7th in the open-access journal PLoS Genetics. The researchers identified this functional link by first identifying the major targets of Foxp2 in developing brain tissue and then analysing the function of relevant neurons. Foxp2 codes for a regulatory protein that provides a window into unusual aspects of brain function. In 2001, scientists discovered that mutations of the human gene cause a rare form of speech and language ...

LAST 30 PRESS RELEASES:

Anna Krylov and Mikhail Yampolsky are the new George Gamow award laureates

Methane from overlooked sources higher than predicted in Osaka

World’s largest rays may be diving to extreme depths to build mental maps of vast oceans

Can we hear gravitational-wave "beats" in the rhythm of pulsars?

New survey shows many are unaware of advancements in obstetrics care

New combination therapy shows promise for aggressive lymphoma resistant to immunotherapy

Photocatalytic olefin double bond cleavage acylation

Unveiling the impact of compound drought and wildfire events on PM2.5 air pollution in the era of climate change

A bioadhesive sponge inspired by mussels and extracellular matrix offers a new way to stop internal bleeding

Poorer health linked to more votes for Reform UK, 2024 voting patterns suggest

Loneliness and social isolation linked to heightened risk of death in those with cancer

Ditch ‘shrink it and pink it’ approach to women’s running shoes, manufacturers urged

Domestic abusers forge ‘trauma bonds’ with victims before violence begins

UK food needs radical transformation on scale not seen since Second World War, new report finds

New AI tool makes medical imaging process 90% more efficient

Nitrogen-fortified nanobiochar boosts soil health and rice productivity

Generative art enhances virtual shopping experience

Fluid-based laser scanning for brain imaging

Concordia study links urban heat in Montreal to unequal greenspace access

Hidden patterns link ribosomal RNAs to genes of the nervous system

Why does losing the Y chromosome make some cancers worse? New $6.5 million NIH grant could provide clues

Xiao receives David W. Robertson Award for Excellence in Medicinal Chemistry

Boron isotopes reveal how nuclear waste glass slowly dissolves over time

Biochar helps Mediterranean vineyards hold water and fight erosion

Checking the quality of materials just got easier with a new AI tool

Does hiding author names make science fairer?

Fatal Attraction: Electric charge connects jumping worm to aerial prey

Rice physicists probe quark‑gluon plasma temperatures, helping paint more detailed picture of big bang

Cellular railroad switches: how brain cells route supplies to build memories

Breast cancer startup founded by WashU Medicine researchers acquired by Lunit

[Press-News.org] Scientists find 'brake-override' proteins that enable development of some cancers